In consideration of the health and safety concerns related to the ongoing global COVID-19 pandemic, the Southern California Society of Gastroenterology (SCSG) has made the difficult decision to host the 2020 SCSG GI and Liver Symposium as a virtual meeting. While we had hoped to offer an in-person gathering, we have realized that convening in Laguna Beach will not be possible this year.
The 2020 SCSG GI and Liver Symposium will be held virtually on December 4-6, 2020. The combined symposium will feature an extra day of programming beginning on Friday December 4th. Consideration is also being given to extending the agenda on Saturday December 5, and Sunday 6 to include important GI topics as well. Additional detail including registration dates are to follow in the coming weeks. We are pleased to announce that registration for the virtual 2020 SCSG GI and Liver Symposium will be free for all current SCSG Members. Please click the button above to renew your membership for 2020.
The symposium provides a unique opportunity to receive a comprehensive update in chronic liver disease and gastrointestinal disorders from nationally renowned faculty. The educational lectures at this symposium focused on important advances presented at the annual American Association for the Study of Liver Disease (AASLD) Meeting and/or in recent publications. Attendees will also have the opportunity to interact with colleagues, our expert faculty members, and industry representatives on our virtual platform.
Please mark your calendar to virtually attend this exciting symposium. Complete conference and registration information will be sent in the upcoming weeks. For questions or inquiries, please contact the SCSG via email at firstname.lastname@example.org.
This activity has been designed to meet the educational needs of physicians, physician assistants, and nurse practitioners involved in the care of patients with chronic liver disease and gastrointestinal disorders.
Statement of Need
The goal of this program is to provide important clinical and scientific data on the management of chronic liver disease and gastrointestinal disorders.
Upon completion of this symposium, participants should be better able to:
Describe chronic liver disease (CLD) management recommendations/guidelines for new treatments, and describe current guidelines for the diagnosis and management of gastrointestinal disorders
Optimize treatment results for patients with CLD, through utilizing new therapies, through utilizing new therapies, and employ an evidence-based approach to the management of gastrointestinal disorders
Identify new advances presented at 2020 AASLD and assess their potential impact on clinical practice
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Southern California Society of Gastroenterology. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of TBD AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables participants to earn up to TBD MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Disclosure of Conflicts of Interest
All faculty and staff involved in the planning or presentation of continuing education activities sponsored/provided by Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.
Learner Assurance Statement
The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
The GI Symposium Co-Chair Committee
Gareth Dulai, MD
Eric Esrailian, MD
Vinay Sundaram, MD
The Liver Symposium Co-Chair Committee
Steven-Huy B. Han, MD
Jeffrey A. Kahn, MD
Paul J. Pockros, MD